🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Accolade CFO sells over $36k in stock to cover tax withholding

Published 06/13/2024, 01:53 PM
ACCD
-

Accolade, Inc. (NASDAQ:ACCD) Chief Financial Officer Stephen H. Barnes has sold shares of the company's common stock, primarily to cover tax withholding obligations related to the vesting of restricted stock units (RSUs). The transactions, which took place on June 12, 2024, resulted in the sale of 5,482 shares at an average price of $6.615 per share, totaling approximately $36,263.

The sale reported was part of a "mandatory sell to cover" transaction, a common practice wherein employees sell a portion of their vested equity to satisfy tax liabilities. This type of sale is generally non-discretionary and is automatically triggered upon the vesting of equity awards, such as RSUs. In Barnes's case, the RSUs vested and were converted into common stock, which was then partially sold to meet tax requirements.

On the previous day, June 11, 2024, Barnes acquired 18,821 shares of common stock as a result of the RSUs vesting. Following these transactions, Barnes's direct ownership in the company stands at 195,223 shares of common stock.

Investors often monitor insider transactions as they can provide insights into executives' perspectives on the company's stock value. However, it is important to note that transactions like these, which are related to tax obligations, may not necessarily reflect the executive's voluntary trading strategy or view on the company's future performance.

Accolade, Inc., headquartered in Plymouth Meeting, Pennsylvania, operates in the business services sector, providing personalized health and benefits solutions designed to improve the experience, outcomes, and cost of healthcare.

In other recent news, Accolade Inc. reported a robust fiscal fourth-quarter growth of over 20%, with a significant increase in adjusted EBITDA and an expectation of a 20% top-line increase for the fiscal year 2025. The healthcare technology company, serving over 14 million individuals and more than 1,200 customers, ended the quarter with $237 million in cash and securities. Meanwhile, Wells Fargo has maintained an Equal Weight rating on Accolade, highlighting the potential for business model disruption due to advancements in artificial intelligence. The firm suggested that the competitive landscape may become more challenging for Accolade, with AI solutions expected to lower the barriers to entry for new competitors. Wells Fargo also adjusted its outlook on Accolade shares, reducing the price target to $10.00 from the prior $12.00 while maintaining an Equal Weight rating. This adjustment reflects a more cautious stance on the company's revenue outlook and a shift in valuation methodology. These are recent developments for Accolade, offering insights into its financial performance and market position.

InvestingPro Insights

In light of the recent insider transactions at Accolade, Inc. (NASDAQ:ACCD), investors may find it useful to consider some key financial metrics and InvestingPro Tips for a broader market perspective. The company's market capitalization stands at $499.92 million, indicating its size within the business services sector. Despite the challenges, Accolade has managed to achieve a revenue growth of 14.09% over the last twelve months as of Q4 2024, showcasing its ability to expand its top-line results in a competitive industry.

However, it's important for investors to be aware of the company's current profitability challenges. Accolade's P/E ratio is -4.8, reflecting the market's concerns about its near-term earnings potential. Analysts do not anticipate the company will be profitable this year, and it has not been profitable over the last twelve months. Additionally, the stock price has been quite volatile, currently trading near its 52-week low, which may suggest a potential opportunity for investors looking for undervalued stocks.

When considering the company's financial health, one positive note is that Accolade's liquid assets exceed its short-term obligations, which may provide some reassurance regarding the company's ability to meet its immediate financial liabilities. Furthermore, the firm operates with a moderate level of debt, which could be a strategic leverage point or a concern depending on future profitability.

For a more comprehensive analysis, including additional InvestingPro Tips such as Accolade's shareholder yield and its position relative to analyst targets, interested parties can explore the full suite of insights available at https://www.investing.com/pro/ACCD. There are 5 additional InvestingPro Tips that could provide further guidance on the stock's outlook. Remember to use coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.